| Year |
Citation |
Score |
| 2020 |
Feng T, Tripathi A, Pillai A. Inflammatory Pathways in Psychiatric Disorders: The case of Schizophrenia and Depression. Current Behavioral Neuroscience Reports. 7: 128-138. PMID 34178573 DOI: 10.1007/s40473-020-00207-4 |
0.323 |
|
| 2020 |
Koola MM, Looney SW, Hong H, Pillai A, Hou W. Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement. Psychiatry Research. 291: 113285. PMID 32763546 DOI: 10.1016/J.Psychres.2020.113285 |
0.399 |
|
| 2020 |
Poddar I, Callahan PM, Hernandez CM, Pillai A, Yang X, Bartlett MG, Terry AV. Oral quetiapine treatment results in time-dependent alterations of recognition memory and brain-derived neurotrophic factor-related signaling molecules in the hippocampus of rats. Pharmacology, Biochemistry, and Behavior. 172999. PMID 32702397 DOI: 10.1016/J.Pbb.2020.172999 |
0.369 |
|
| 2020 |
Poddar I, Callahan PM, Hernandez CM, Pillai A, Yang X, Bartlett MG, Terry AV. Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in rats. Pharmacology, Biochemistry, and Behavior. 172853. PMID 31945381 DOI: 10.1016/J.Pbb.2020.172853 |
0.413 |
|
| 2020 |
Koola M, Jafarnejad S, Looney S, Praharaj S, Pillai A, Ahmed A, Slifstein M. Meta-Analyses of Randomized Controlled Trials and Potential Novel Combination Treatments in Schizophrenia Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.789 |
0.395 |
|
| 2020 |
Feng T, Tripathi A, Pillai A. Inflammatory Pathways in Psychiatric Disorders: the Case of Schizophrenia and Depression Current Behavioral Neuroscience Reports. 7: 128-138. DOI: 10.1007/S40473-020-00207-4 |
0.41 |
|
| 2019 |
Koola MM, Praharaj SK, Pillai A. Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia. Current Behavioral Neuroscience Reports. 6: 37-50. PMID 32601581 DOI: 10.1007/S40473-019-00174-5 |
0.449 |
|
| 2019 |
Weickert CS, Lee CH, Lenroot RK, Bruggemann J, Galletly C, Liu D, Balzan R, Pillai A, Buckley P, Weickert TW. Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia. Schizophrenia Research. PMID 31088701 DOI: 10.1016/J.Schres.2019.04.015 |
0.383 |
|
| 2019 |
Koola M, Pillai A, Looney S. F198. Antipsychotic-Galantamine-Memantine Combination: Does it Have Enough Missiles to Fire Against the MIGHTY Schizophrenia? Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.735 |
0.397 |
|
| 2018 |
Crider A, Feng T, Pandya CD, Davis T, Nair A, Ahmed A, Baban B, Turecki G, Pillai A. Complement component 3a receptor deficiency attenuates ch nronic stress-induced monocyte infiltration and depressive-like behavior. Brain, Behavior, and Immunity. PMID 29518530 DOI: 10.1016/J.Bbi.2018.03.004 |
0.324 |
|
| 2018 |
Crider A, Nelson T, Davis T, Fagan K, Vaibhav K, Luo M, Kamalasanan S, Terry AV, Pillai A. Estrogen Receptor β Agonist Attenuates Endoplasmic Reticulum Stress-Induced Changes in Social Behavior and Brain Connectivity in Mice. Molecular Neurobiology. PMID 29430617 DOI: 10.1007/S12035-018-0929-8 |
0.383 |
|
| 2017 |
Pillai A, Schooler NR, Peter D, Looney SW, Goff DC, Kopelowicz A, Lauriello J, Manschreck T, Mendelowitz A, Miller DD, Severe JB, Wilson DR, Ames D, Bustillo J, Kane JM, et al. Predicting relapse in schizophrenia: Is BDNF a plausible biological marker? Schizophrenia Research. PMID 28734907 DOI: 10.1016/J.Schres.2017.06.059 |
0.385 |
|
| 2017 |
Buckley P, Pillai A. 726. Predicting Relapse in Schizophrenia: Is BDNF a Plausible Biological Marker? Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.793 |
0.432 |
|
| 2017 |
Crider A, Luo M, Davis T, Baban B, Pillai A. Maternal ER stress induces ASD-like behavior in mice through the IL-17a pathway Brain, Behavior, and Immunity. 66: e23. DOI: 10.1016/J.Bbi.2017.07.090 |
0.325 |
|
| 2016 |
Crider A, Pillai A. Estrogen signaling as a therapeutic target in neurodevelopmental disorders. The Journal of Pharmacology and Experimental Therapeutics. PMID 27789681 DOI: 10.1124/Jpet.116.237412 |
0.448 |
|
| 2016 |
Crider A, Pillai A. The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia. Current Behavioral Neuroscience Reports. 3: 154-164. PMID 27695666 DOI: 10.1007/S40473-016-0079-0 |
0.384 |
|
| 2016 |
Phillips KE, Jimerson DC, Pillai A, Wolfe BE. Plasma BDNF levels following weight recovery in anorexia nervosa. Physiology & Behavior. PMID 27542517 DOI: 10.1016/J.Physbeh.2016.08.014 |
0.315 |
|
| 2015 |
Pillai A, Howell KR, Ahmed AO, Weinberg D, Allen KM, Bruggemann J, Lenroot R, Liu D, Galletly C, Weickert CS, Weickert TW. Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Molecular Psychiatry. PMID 26169975 DOI: 10.1038/Mp.2015.96 |
0.764 |
|
| 2015 |
Howell KR, Pillai A. Long-Term Effects of Prenatal Hypoxia on Schizophrenia-Like Phenotype in Heterozygous Reeler Mice. Molecular Neurobiology. PMID 26059812 DOI: 10.1007/S12035-015-9265-4 |
0.766 |
|
| 2014 |
Crider A, Pandya CD, Peter D, Ahmed AO, Pillai A. Ubiquitin-proteasome dependent degradation of GABAAα1 in autism spectrum disorder. Molecular Autism. 5: 45. PMID 25392730 DOI: 10.1186/2040-2392-5-45 |
0.305 |
|
| 2014 |
Buckley PF, Miller BJ, Pillai A, Kirkpatrick B. Cysteamine, a pro-BDNF drug, as an adjunctive treatment for schizophrenia. Schizophrenia Research. 158: 268-9. PMID 25052781 DOI: 10.1016/j.schres.2014.06.030 |
0.324 |
|
| 2014 |
Howell KR, Pillai A. Effects of prenatal hypoxia on schizophrenia-related phenotypes in heterozygous reeler mice: a gene × environment interaction study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1324-36. PMID 24946696 DOI: 10.1016/J.Euroneuro.2014.05.011 |
0.754 |
|
| 2014 |
Koola MM, Buchanan RW, Pillai A, Aitchison KJ, Weinberger DR, Aaronson ST, Dickerson FB. Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia. Schizophrenia Research. 157: 84-9. PMID 24878431 DOI: 10.1016/J.Schres.2014.04.037 |
0.415 |
|
| 2014 |
Pandya C, Kutiyanawalla A, Turecki G, Pillai A. Glucocorticoid regulates TrkB protein levels via c-Cbl dependent ubiquitination: a decrease in c-Cbl mRNA in the prefrontal cortex of suicide subjects. Psychoneuroendocrinology. 45: 108-18. PMID 24845182 DOI: 10.1016/J.Psyneuen.2014.03.020 |
0.417 |
|
| 2014 |
Rosenquist PB, Miller B, Pillai A. The antipsychotic effects of ECT: a review of possible mechanisms. The Journal of Ect. 30: 125-31. PMID 24810776 DOI: 10.1097/Yct.0000000000000131 |
0.325 |
|
| 2014 |
Pandya CD, Crider A, Pillai A. Glucocorticoid regulates parkin expression in mouse frontal cortex: implications in schizophrenia. Current Neuropharmacology. 12: 100-7. PMID 24669205 DOI: 10.2174/1570159X11666131120224950 |
0.417 |
|
| 2013 |
Pandya CD, Hoda MN, Kutiyanawalla A, Buckley PF, Pillai A. Differential effects upon brain and serum BDNF levels in rats as response to continuous and intermittent administration strategies of two second generation antipsychotics. Schizophrenia Research. 151: 287-8. PMID 24135222 DOI: 10.1016/J.Schres.2013.09.027 |
0.34 |
|
| 2013 |
Howell KR, Hoda MN, Pillai A. VEGF activates NR2B phosphorylation through Dab1 pathway. Neuroscience Letters. 552: 30-4. PMID 23916658 DOI: 10.1016/J.Neulet.2013.07.032 |
0.722 |
|
| 2013 |
Pandya CD, Kutiyanawalla A, Pillai A. BDNF-TrkB signaling and neuroprotection in schizophrenia. Asian Journal of Psychiatry. 6: 22-8. PMID 23380313 DOI: 10.1016/J.Ajp.2012.08.010 |
0.507 |
|
| 2013 |
Pandya CD, Howell KR, Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 46: 214-23. PMID 23123357 DOI: 10.1016/J.Pnpbp.2012.10.017 |
0.72 |
|
| 2012 |
Pillai A, Bruno D, Sarreal AS, Hernando RT, Saint-Louis LA, Nierenberg J, Ginsberg SD, Pomara N, Mehta PD, Zetterberg H, Blennow K, Buckley PF. Plasma BDNF levels vary in relation to body weight in females. Plos One. 7: e39358. PMID 22768299 DOI: 10.1371/Journal.Pone.0039358 |
0.316 |
|
| 2012 |
Kutiyanawalla A, Promsote W, Terry A, Pillai A. Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1073-86. PMID 21777509 DOI: 10.1017/S1461145711001180 |
0.466 |
|
| 2011 |
Kutiyanawalla A, Terry AV, Pillai A. Cysteamine attenuates the decreases in TrkB protein levels and the anxiety/depression-like behaviors in mice induced by corticosterone treatment. Plos One. 6: e26153. PMID 22039440 DOI: 10.1371/Journal.Pone.0026153 |
0.375 |
|
| 2011 |
Howell KR, Kutiyanawalla A, Pillai A. Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex. Plos One. 6: e20198. PMID 21647420 DOI: 10.1371/Journal.Pone.0020198 |
0.762 |
|
| 2011 |
Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor: findings in schizophrenia. Current Opinion in Psychiatry. 24: 122-7. PMID 21248641 DOI: 10.1097/Yco.0B013E3283436Eb7 |
0.755 |
|
| 2011 |
Terry AV, Buccafusco JJ, Gearhart DA, Beck WD, Middlemore-Risher ML, Truan JN, Schwarz GM, Xu M, Bartlett MG, Kutiyanawala A, Pillai A. Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function. Neuroscience. 176: 237-53. PMID 21185910 DOI: 10.1016/J.Neuroscience.2010.12.031 |
0.321 |
|
| 2011 |
Terry AV, Kutiyanawalla A, Pillai A. Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats. Physiology & Behavior. 102: 149-57. PMID 21059364 DOI: 10.1016/J.Physbeh.2010.11.005 |
0.327 |
|
| 2010 |
Issa G, Wilson C, Terry AV, Pillai A. An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiology of Disease. 39: 327-33. PMID 20451611 DOI: 10.1016/J.Nbd.2010.04.017 |
0.508 |
|
| 2010 |
Terry AV, Gearhart DA, Pillai A, Zhang G, Bartlett MG. Chronic antipsychotic treatment: protracted decreases in phospho-TrkA levels in the rat hippocampus. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 799-805. PMID 20059802 DOI: 10.1017/S1461145709991040 |
0.47 |
|
| 2010 |
Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, Mahadik SP. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 535-9. PMID 19941699 DOI: 10.1017/S1461145709991015 |
0.384 |
|
| 2010 |
Buckley P, Pillai A. DEFICITS IN BRAIN DERIVED NEUROTROPHIC FACTORS: POTENTIAL AS AN EARLY-PHASE BIOMARKER FOR SCHIZOPHRENIA? Schizophrenia Research. 117: 125. DOI: 10.1016/j.schres.2010.02.072 |
0.327 |
|
| 2009 |
Kale A, Joshi S, Pillai A, Naphade N, Raju M, Nasrallah H, Mahadik SP. Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients. Schizophrenia Research. 115: 209-14. PMID 19713082 DOI: 10.1016/J.Schres.2009.07.022 |
0.377 |
|
| 2009 |
Fulzele S, Pillai A. Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects. Schizophrenia Research. 115: 372-3. PMID 19576729 DOI: 10.1016/j.schres.2009.06.005 |
0.349 |
|
| 2008 |
Terry AV, Warner SE, Vandenhuerk L, Pillai A, Mahadik SP, Zhang G, Bartlett MG. Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats. Neuroscience. 156: 1005-16. PMID 18801413 DOI: 10.1016/J.Neuroscience.2008.08.030 |
0.364 |
|
| 2008 |
Pillai A, Veeranan-Karmegam R, Dhandapani KM, Mahadik SP. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex. Journal of Neurochemistry. 107: 941-51. PMID 18786174 DOI: 10.1111/J.1471-4159.2008.05665.X |
0.459 |
|
| 2008 |
Pillai A. Decreased expression of Sprouty2 in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder: a correlation with BDNF expression. Plos One. 3: e1784. PMID 18335055 DOI: 10.1371/Journal.Pone.0001784 |
0.518 |
|
| 2008 |
Pillai A. Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia. Neuro-Signals. 16: 183-93. PMID 18253057 DOI: 10.1159/000111562 |
0.474 |
|
| 2008 |
Pillai A, Mahadik SP. Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophrenia Research. 100: 325-33. PMID 18187310 DOI: 10.1016/J.Schres.2007.11.030 |
0.483 |
|
| 2008 |
Kale A, Joshi S, Naphade N, Sapkale S, Raju MS, Pillai A, Nasrallah H, Mahadik SP. Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients. Schizophrenia Research. 98: 295-301. PMID 17997280 DOI: 10.1016/J.Schres.2007.09.036 |
0.395 |
|
| 2008 |
Pillai A, Dhandapani KM, Pillai BA, Terry AV, Mahadik SP. Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNF. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1942-51. PMID 17805306 DOI: 10.1038/Sj.Npp.1301566 |
0.46 |
|
| 2007 |
Buckley PF, Mahadik S, Pillai A, Terry A. Neurotrophins and schizophrenia Schizophrenia Research. 94: 1-11. PMID 17524622 DOI: 10.1016/J.Schres.2007.01.025 |
0.471 |
|
| 2007 |
Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S. Brain derived neurotropic factor in first-episode psychosis Schizophrenia Research. 91: 1-5. PMID 17306505 DOI: 10.1016/J.Schres.2006.12.026 |
0.477 |
|
| 2006 |
Pillai A, Mahadik SP. Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus. Schizophrenia Research. 87: 48-59. PMID 16859894 DOI: 10.1016/j.schres.2006.06.017 |
0.315 |
|
| 2006 |
Pillai A, Terry AV, Mahadik SP. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophrenia Research. 82: 95-106. PMID 16442781 DOI: 10.1016/J.Schres.2005.11.021 |
0.401 |
|
| 2006 |
Buckley P, Pillai A, Stirewalt E, Evans D, Mahadik S. 0167 DEFICITS IN BRAIN DERIVED NEUROTROPHIC FACTOR AT THE ONSET OF SCHIZOPHRENIA Schizophrenia Research. 86: S71. DOI: 10.1016/S0920-9964(06)70212-2 |
0.46 |
|
| Show low-probability matches. |